Lawrence, KS, United States of America

Richard D Shaffer

This inventor holds 1 USPTO granted patent. Top assignee: Interx Research Corporation. Active years: 1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard D Shaffer. Retrieved from https://idiyas.com/inventor/richard-d-shaffer-y4ftk4vf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard D. Shaffer: Innovator in Pharmaceutical Science

Introduction

Richard D. Shaffer is a notable inventor based in Lawrence, Kansas, who has made significant contributions to the field of pharmaceutical science. He is recognized for his innovative approach to drug formulation, particularly in the development of enteric-coated medications.

Latest Patents

Richard D. Shaffer holds a patent for "Enteric coated digoxin and therapeutic use thereof." This invention focuses on achieving therapeutic and undegraded levels of digoxin in warm-blooded animals through the oral administration of a non-toxic pharmaceutical enteric-coated tablet. This advancement has the potential to improve the efficacy and safety of digoxin therapy.

Career Highlights

Shaffer is associated with Interx Research Corporation, where he applies his expertise in pharmaceutical development. His work at the company emphasizes the importance of innovative drug delivery systems and their impact on patient care.

Collaborations

One of his notable collaborators is John J. Windheuser, with whom he has worked on various projects aimed at enhancing pharmaceutical formulations.

Conclusion

Richard D. Shaffer's contributions to pharmaceutical science, particularly through his patent on enteric-coated digoxin, highlight his role as an innovator in the field. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…